Clinical model FPR 10% | Clonal model FPR 10% | Concordance between clinical and clonal modelsa | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
R5 | X4 | R5/X4 | p-value* | R5 | X4 | R5/X4 | p-value* | R5-R5 | R5-X4 | X4-R5 | X4-X4 | p-value** | |
Number (%) | 285 (81) | 60 (17) | 7 (2) | 291 (82.7) | 50 (14.2) | 11 (3.1) | 245 (69.6) | 40 (11.4) | 46 (13.0) | 21 (6.0) | |||
CD4 cells/ul median (IQR) | 132 (76–193) | 41 (21–98) | 130 (107–220) | <0.001 | 125 (67–189) | 89 (42–140) | 160 (72–177) | 0.08 | 135 (77–196) | 127 (74–188) | 55 (21–128) | 70 (22–91) | <0.001 |
VL median (IQR) | 5.3 (4.8–5.8) | 5.4 (5.1–5.8) | 5.3 (4.4–5.7) | 0.18 | 5.4 (4.9–5.8) | 5.4 (5–5.9) | 5.4 (4.7–5.7 | 0.50 | 5.3 (4.8–5.8) | 5.4 (5.1–5.9) | 5.3 (4.4–5.7) | 5.8 (5.3–5.9) | 0.170 |